{"id":"W2892791765","doi":"10.1136/annrheumdis-2018-eular.2641","title":"OP0334 Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adalimumab; Axial spondyloarthritis; Internal medicine; BASDAI; Clinical endpoint; Etanercept; Placebo; Gastroenterology; Ankylosing spondylitis; Randomized controlled trial; Arthritis; Disease; Tumor necrosis factor alpha; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002003868,0.0005280884,0.001844913,0.0002592213,0.0002875899,0.0009594328,0.0005446736,0.001010993,0.002183739],"category_scores_gemma":[0.002781544,0.0002644876,0.001875594,0.0003274828,0.0006541238,0.0011682,0.0003527894,0.002545789,0.000401385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005024811,"about_ca_system_score_gemma":0.0008123353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001008246,"about_ca_topic_score_gemma":0.001380584,"domain_scores_codex":[0.9990222,0.0003712529,0.0001092102,0.0001651356,0.0000999489,0.0002321874],"domain_scores_gemma":[0.9981711,0.0007776162,0.0003344546,0.0001644367,0.00008988925,0.0004624761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8471965,0.006029324,0.01997262,0.0004095112,0.001523509,0.000142146,0.000179215,0.0007762498,0.008212629,0.0001564728,0.0005783027,0.1148235],"study_design_scores_gemma":[0.1899607,0.556749,0.2374125,0.0002193194,0.004593545,0.0005760845,0.0002834768,0.003201135,0.004547013,0.0005913725,0.001753249,0.0001126525],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969484,0.002077887,0.00006646556,0.0001269031,0.00005853433,0.00004145693,0.00014324,0.00001687524,0.0005200388],"genre_scores_gemma":[0.9988806,0.0004038889,0.0001161812,0.0001180079,0.00006218761,0.00002996147,0.0001759303,0.000003362051,0.0002099519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002183739,"threshold_uncertainty_score":0.01059759,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01373599523036244,"score_gpt":0.2686657211245,"score_spread":0.2549297258941375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}